| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
389,580,000 |
| Market
Cap: |
50.01(B) |
| Last
Volume: |
1,778,975 |
Avg
Vol: |
1,913,734 |
| 52
Week Range: |
$75.49 - $140.45 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 487 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
214,480 |
283,298 |
303,316 |
571,262 |
| Total Sell Value |
$28,881,982 |
$37,155,070 |
$39,545,240 |
$69,827,197 |
| Total People Sold |
7 |
12 |
14 |
16 |
| Total Sell Transactions |
14 |
29 |
47 |
80 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Altman Steven R |
Director |
– • – |
2023-09-15 |
4 |
AS |
$101.50 |
$101,495 |
I/I |
(1,000) |
61,700 |
|
31% |
|
| Heller Bridgette P |
Director |
– • – |
2023-09-12 |
4 |
AS |
$106.56 |
$63,936 |
D/D |
(600) |
23,731 |
|
23% |
|
| Selvaraj Shelly Ramasamy |
SVP Chief Information Officer |
• – – |
2023-09-11 |
4 |
D |
$105.25 |
$215,241 |
D/D |
(2,045) |
48,453 |
|
- |
|
| Driscoll Rimma |
Director |
– • – |
2023-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,008 |
4,008 |
|
- |
|
| Pacelli Steven Robert |
EVP Managing Director Dexcom V |
• – – |
2023-08-23 |
4 |
AS |
$107.03 |
$43,989 |
D/D |
(411) |
126,008 |
|
18% |
|
| Sylvain Jereme M |
EVP Chief Financial Officer |
• – – |
2023-08-22 |
4 |
AS |
$104.38 |
$192,477 |
D/D |
(1,844) |
72,867 |
|
16% |
|
| Dahut Karen M |
Director |
– • – |
2023-08-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,544 |
12,260 |
|
- |
|
| Dahut Karen M |
Director |
– • – |
2023-08-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,544 |
2,906 |
|
- |
|
| Stern Sadie |
EVP Chief Human Resources Offi |
• – – |
2023-08-09 |
4 |
AS |
$110.71 |
$43,398 |
D/D |
(392) |
81,682 |
|
10% |
|
| Pacelli Steven Robert |
EVP Managing Director Dexcom V |
• – – |
2023-07-24 |
4 |
AS |
$130.58 |
$53,799 |
D/D |
(412) |
126,419 |
|
-9% |
|
| Pacelli Steven Robert |
EVP Managing Director Dexcom V |
• – – |
2023-07-14 |
4 |
AS |
$136.00 |
$684,216 |
D/D |
(5,031) |
126,831 |
|
-21% |
|
| Regan Barry J. |
EVP Operations |
• – – |
2023-07-10 |
4 |
AS |
$128.05 |
$254,691 |
D/D |
(1,989) |
66,269 |
|
-22% |
|
| Stern Sadie |
EVP Chief Human Resources Offi |
• – – |
2023-07-10 |
4 |
AS |
$128.05 |
$50,196 |
D/D |
(392) |
82,074 |
|
-22% |
|
| Pacelli Steven Robert |
EVP Managing Director Dexcom V |
• – – |
2023-06-23 |
4 |
AS |
$125.92 |
$51,879 |
D/D |
(412) |
131,862 |
|
-30% |
|
| Selvaraj Shelly Ramasamy |
SVP Chief Information Officer |
• – – |
2023-06-15 |
4 |
AS |
$130.00 |
$274,953 |
D/D |
(2,115) |
50,390 |
|
-34% |
|
| Stern Sadie |
EVP Chief Human Resources Offi |
• – – |
2023-06-09 |
4 |
AS |
$121.31 |
$47,675 |
D/D |
(393) |
82,466 |
|
-32% |
|
| Pacelli Steven Robert |
EVP Managing Director Dexcom V |
• – – |
2023-05-23 |
4 |
AS |
$118.65 |
$48,884 |
D/D |
(412) |
132,274 |
|
-18% |
|
| Sylvain Jereme M |
EVP Chief Financial Officer |
• – – |
2023-05-22 |
4 |
AS |
$117.58 |
$282,192 |
D/D |
(2,400) |
74,711 |
|
-22% |
|
| Foletta Mark G |
Director |
– • – |
2023-05-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,488 |
59,092 |
|
- |
|
| Foletta Mark G |
Director |
– • – |
2023-05-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,488 |
3,306 |
|
- |
|
| Foletta Mark G |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$3 |
D/D |
3,306 |
7,794 |
|
- |
|
| Heller Bridgette P |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$3 |
D/D |
2,911 |
24,331 |
|
- |
|
| Collins Richard Alexander |
Director |
– • – |
2023-05-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,948 |
36,404 |
|
- |
|
| Collins Richard Alexander |
Director |
– • – |
2023-05-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,948 |
2,906 |
|
- |
|
| Collins Richard Alexander |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$3 |
D/D |
2,906 |
6,854 |
|
- |
|
1713 Records found
|
|
Page 3 of 69 |
|
|
1.72 (1.36%) 
